Search results
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 21 hours agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 1 day agoThe disclosure came amid a run-up in shares of vaccine makers. Moderna stock spiked in Wednesday...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 16 hours agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 15 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 6 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Moderna’s long Covid plan
Politico· 14 hours agoWhat’s next? Rizkalla said he sees some promise in antiviral treatments, which may clear residual virus after an infection, or vaccines, perhaps to...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Moderna Has Big AI News. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoThe biotech could become an AI winner down the road, but does this make the stock a buy? Let's find out. Image source: Getty Images. Moderna's peak ...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 16 hours agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 7 days agoThe EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the...
